Skip to main content
. Author manuscript; available in PMC: 2011 Feb 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2009 Dec 23;243(1):1–12. doi: 10.1016/j.taap.2009.12.010

Figure 3.

Figure 3

Dyslipidemic changes in acrolein-fed C57BL/6 mice. Adult (8–12 week old) male mice were gavage-fed acrolein (5 mg/kg) and 24h later plasma lipoproteins were separated by FPLC and ultracentrifugation. FPLC elution profile of (A) cholesterol and (B) triglycerides in plasma isolated from water-fed (black line) or acrolein-fed (dotted line) mice. Individual lipoprotein fractions are indicated. (C) Agarose gel electrophoresis of ultracentrifugation fractions isolated from water-fed (control) or acrolein-fed (treated) mice. HDL-rich lipoproteins displayed the highest mobility as indicated. (D) Serum amyloid A levels in control and acrolein-treated mice. Data are shown as mean ± S.E.M., * P<0.05; n=5.